Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not
- PMID: 34258722
- DOI: 10.1245/s10434-021-10432-0
Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not
Comment in
-
Reply to: Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not.Ann Surg Oncol. 2021 Dec;28(Suppl 3):795-796. doi: 10.1245/s10434-021-10434-y. Epub 2021 Jul 17. Ann Surg Oncol. 2021. PMID: 34275041 No abstract available.
Comment on
-
Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes.Ann Surg Oncol. 2021 Nov;28(12):7476-7486. doi: 10.1245/s10434-021-09837-8. Epub 2021 Apr 23. Ann Surg Oncol. 2021. PMID: 33891203
References
-
- Kong JC, Soucisse M, Michael M, et al. Total neoadjuvant therapy in locally advanced rectal cancer: a systematic review and metaanalysis of oncological and operative outcomes. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09837-8 . - DOI - PubMed
-
- Ciseł B, Pietrzak L, Michalski W, et al. Long-course preoperative chemoradiation versus 5 × 5-Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Ann Oncol. 2019;30:1298–303. - DOI
-
- Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702–15. https://doi.org/10.1016/S1470-2045(21)00079-6 . - DOI - PubMed
-
- Garant A, Kavan P, Martin AG, et al. Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: the KIR randomized phase II trial. Radiother Oncol. 2021;155:237–45. - DOI
-
- Fernandez-Martos C, Garcia-Albeniz X, Pericay C, et al. Chemoradiation, surgery, and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial. Ann Oncol. 2015;26:1722–8. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
